Maternal HIV infection and the milk microbiome
Nicole H. Tobin(National Institutes of Health), Dhayendre Moodley(Centre for the AIDS Programme of Research in South Africa), Avy Violari(University of the Witwatersrand), Vanessa Rouzier(Gheskio Centers), Sean S. Brummel(Harvard University), Louise Kuhn(Columbia University), Grace M. Aldrovandi(Children's Hospital of Philadelphia), Fan Li(Guangzhou University of Chinese Medicine), Mary Glenn Fowler(Johns Hopkins University), Sufia Dababhai(University of Malawi), Patricia M. Flynn(St. Jude Children's Research Hospital), Lameck Chinula
Cited by 8
Related Papers
Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2009|3.6k
Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial
|The Lancet|1999|1.7k
Maternal Viral Load, Zidovudine Treatment, and the Risk of Transmission of Human Immunodeficiency Virus Type 1 from Mother to Infant
|New England Journal of Medicine|1996|817
MRP4: A previously unidentified factor in resistance to nucleoside-based antiviral drugs
|Nature Medicine|1999|580
Risk Factors for Perinatal Transmission of Human Immunodeficiency Virus Type 1 in Women Treated with Zidovudine
|New England Journal of Medicine|1999|553